Arcus Capital Partners, LLC Thermo Fisher Scientific Inc. Transaction History

Arcus Capital Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 23, 2024	BUY	$431.41 - $532.94 $471,531 - $582,503	1,093 New	1,093 $580,000
Q1 2023 May 09, 2023	BUY	$535.0 - $604.82 $326,885 - $369,545	611 Added 74.69%	1,429 $823,000
Q4 2022 Jan 27, 2023	SELL	$484.71 - $571.37 $642,240 - $757,065	-1,325 Reduced 61.83%	818 $0
Q3 2022 Oct 25, 2022	BUY	$507.19 - $604.49 $351,989 - $419,516	694 Added 47.9%	2,143 $1.09 Million
Q2 2022 Jul 29, 2022	SELL	$500.9 - $612.21 $3,506 - $4,285	-7 Reduced 0.48%	1,449 $787,000
Q1 2022 May 04, 2022	SELL	$524.0 - $644.92 $3,144 - $3,869	-6 Reduced 0.41%	1,456 $860,000
Q4 2021 Jan 28, 2022	BUY	$569.0 - $667.24 $378,385 - $443,714	665 Added 83.44%	1,462 $976,000
Q3 2021 Oct 26, 2021	BUY	$509.53 - $609.78 $406,095 - $485,994	797 New	797 $455,000

2,812

332M

2.37M

2.75M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $234B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Arcus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Arcus Capital Partners, LLC with notifications on news.